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Abstract
Myelination organizes axons into distinct domains that allow nerve impulses to propagate in a
saltatory manner. The edges of the myelin sheath are sealed at the paranodes by axon–glial junctions
that have a crucial role in organizing the axonal cytoskeleton. Here we propose a model in which the
myelinated axons depend on the axon–glial junctions to stabilize the cytoskeletal transition at the
paranodes. Thus paranodal regions are likely to be particularly susceptible to damage induced by
demyelinating diseases such as multiple sclerosis.
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INTRODUCTION
In vertebrates, neurons project axons over long distances and, to ensure fast nerve-impulse
conduction in an energetically economic fashion, some of these axons are targeted for
myelination and become insulated by specialized glia (oligodendrocytes in the CNS and
Schwann cells in the PNS). Myelination, ultimately, allows the impulse to propagate in a
saltatory manner by preventing ionic leakage along insulated segments of the axons. There are
differences between myelination in the CNS and PNS such as protein composition, number of
axonal segments myelinated by each myelinating cell, the type of glia contacting the nodes of
Ranvier, and the presence of a basal lamina. Most of the features that we discuss here are
thought to be shared by both the CNS and the PNS. We focus our discussion on the changes
in axonal cytoskeleton promoted by myelination and speculate on the contribution of these
changes to the dependence of myelinated axons on proper contacts with the myelinating glial
cells.
The landmarks for the myelination process include: (1) axonal outgrowth and glial migration
to the region of future white matter; (2) targeting of axons for myelination; (3) bidirectional
signaling between axons and glia that triggers glial differentiation, polarization of glia and
axons into nodes of Ranvier and adjacent molecular domains, and local changes in both glial
and axonal architectures; and (4) dependence on cell–cell interactions for survival of both
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myelinating glia and myelinated axons (Barres and Barde, 2000; Witt and Brady, 2000; Pedraza
et al., 2001; Corfas et al., 2004; Edgar and Garbern, 2004).
Myelination: a selective process
Axons must have a minimum axonal diameter to become a target for myelination, and proper
contact between axons and glia is required for glial differentiation and survival mediated by
the axonal signals (Sherman and Brophy, 2005). In the PNS, the protein Neuregulin 1 (Nrg1)
type III, which is expressed on the axolemma (axonal membrane), is proposed to serve as a
measurement tool for this selection. Because a threshold level of Nrg1 type III is required for
further development of the Schwann cells, only axons that display more than this threshold
level (i.e. those with more than the minimum membrane surface) provide sufficient Nrg1 type
III signaling to be myelinated by Schwann cells (Michailov et al., 2004).
Myelination drives polarization of both the glia and the axons that is coordinated in time and
space, resulting in the formation of distinct domains: nodes of Ranvier, paranodes,
juxtaparanodes and internodes (Fig. 1A). Each segment of axon wrapped by a compact portion
of the myelin sheath corresponds to an internode. Nodes of Ranvier are gaps in the myelin
sheath where voltage-gated Na+ channels are clustered in the axonal membrane. The paranodes
flank the nodes of Ranvier and form the axon–glial junctions (AGJs). Juxtaparanodes are a
specialized region of the internodes that flank the paranodes. Here we provide a brief overview
of these domains. Several recent reviews have focused on how the node of Ranvier and adjacent
domains are established and maintained in myelinated axons (Arroyo and Scherer, 2000;Peles
and Salzer, 2000;Pedraza et al., 2001;Salzer, 2003;Bhat, 2003;Rasband, 2004).
At the internodes, the glial cytoplasm is extruded during myelination, which results in the
formation of layers of a compact lipoprotein coat (Fig. 2A). Accumulation of glial cytoplasm
at the lateral edges of each layer form the paranodal loops. Beneath the glial internodes, in
some axons the axonal internodes also experience a myelination-induced regulation in their
volume, and axonal diameter increases by up to five-fold in the internodal region compared
with the nodes of Ranvier (Figs. 1B and 2A) (Windebank et al., 1985). This expansion is a
consequence of the trophic reorganization of the axonal cytoskeleton and correlates with the
local phosphorylation of neurofilaments and a subsequent increase in neurofilament spacing
(Fig. 1B) (de Waegh et al., 1992). Phosphorylation has been proposed to increase the spacing
between the filaments in vitro by generating electrostatic repulsion of negatively-charged side-
arms at the C-terminal of neurofilament subunits M and H (Kumar and Hoh, 2004). However
studies of neurofilament gene replacement in mice indicate that electrostatic repulsion is not
the sole mechanism by which phosphorylation increases neurofilament spacing in vivo (Garcia
et al., 2003).
The juxtaparanodes form at the region where compaction of the myelin sheath relaxes the inner
layer to allow the formation of the paranodal loops. The function of the juxtaparanode is still
unclear, but this domain is recognized by clustering of specific proteins such as TAG-1 and
connexin-29 on the glial side and K+ channels, Caspr-2, protein 4.1B and PSD-95 on the axonal
side (Fig. 2B) (Rasband, 2004).
The paranodal loops provide the region of closest contact between the myelinating glia and the
axons. Paranodes are the site of assembly of AGJs, which resemble the invertebrate septate
junctions (Einheber et al., 1997; Banerjee et al., 2006). In mouse mutants with disrupted AGJs,
the paranodal domain does not form transverse bands and juxtaparanodal proteins on the axonal
side localize at the region coordinated with the glial paranodal loops (Dupree et al., 1999; Bhat
et al., 2001; Boyle et al., 2001). The consequence is a direct contact between proteins of
juxtaparanodes and nodes of Ranvier, which indicates that AGJs normally serve as a ‘fence’
to segregate the axonal domains that flank the nodes of Ranvier (Rios et al., 2003). The
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molecular components of paranodes that are known are the 155 kDa isoform of neurofascin,
NF155, on the glial side and Caspr (also known as Paranodin and NCP1), contactin (Cont),
protein 4.1B, αII-spectrin, βII-spectrin and ankyrin-B on the axonal side (Fig. 2C) (Einheber
et al., 1997; Menegoz et al., 1997; Bellen et al., 1998; Bhat et al., 2001; Charles et al., 2002;
Denisenko-Nehrbass et al., 2003; Garcia-Fresco et al., 2006; Ogawa et al., 2006). Contactin
is also synthesized by oligodendrocytes during maturation, but has not been detected on the
glial side of the paranodes (Gennarini et al., 1989; Faivre-Sarrailh et al., 1992; Koch et al.,
1997).
The node of Ranvier provides the site for clustering of the voltage-gated Na+ and K+ channels
for ion exchange (Devaux et al., 2003; Poliak and Peles, 2003; Devaux et al., 2004; Schwarz
et al., 2006). In addition to these channels, the main molecular components of the nodes are
Nr-CAM and NF186 at the axolemma, and βIV-spectrin and ankyrin-G in the axonal cytoplasm
(Fig. 2D) (Poliak and Peles, 2003).
Axon–glial communication
Proper communication between axons and glial cells is a feature of the myelination process.
Axons communicate their diameter to glia, which use this information to adjust accordingly
the number of myelin wraps, resulting in a highly regulated ratio between axonal diameter and
myelin thickness, known as the g ratio. The diameter of a myelinated axon also correlates with
the length of the paranode (which correlates with the number of paranodal loops that contact
the axons) and the length of the internodes. The mechanisms that dictate the internodal length
in myelinated axons are unclear (Friede and Samorajski, 1967; Friede and Bischhausen,
1980; Friede and Bischhausen, 1982).
Analysis of myelin thickness in mice that are deficient in phosphorylation of neurofilaments
because of deletion of the phosphorylable isoforms of neurofilament (NF-M, NF-H and NF-
M/H) indicated that Schwann cells and oligodendrocytes read different axonal signals for
establishment of the g ratio (Elder et al., 2001). In these mutants, the expected g ratio was
maintained in CNS axons, whereas it was decreased in PNS axons. This suggests that the CNS
axons relay to oligodendrocytes about their diameter after myelination-induced axonal
expansion, whereas PNS axons relay to Schwann cells about their future diameter during initial
contact or shortly thereafter. Because PNS axons of the above mutants do not undergo the
axonal expansion that is regulated normally via phosphorylation of neurofilaments, the
myelination thickness is increased in relation to the final axonal diameter, and the g ratio is
decreased (Elder et al., 2001). Similar observations have been made in the sciatic nerve of
periaxin-null mice that do not undergo significant myelination-induced axonal expansion and
have a decreased g ratio (Williams and Brophy, 2002). Recent studies by Nave and colleagues
have demonstrated that it is possible to alter the g ratio in the PNS through manipulating
expression of Nrg1 type III in transgenic mice. This indicates that these axons communicate
their diameter to glia through Nrg1 type III on the axolemma. At the glial membrane, ErbB2
binding to Nrg1 type III triggers signaling for glial extension into wrapping layers (Michailov
et al., 2004). These studies indicate that CNS and PNS glia might receive axonal signaling for
regulation of the g ratio at different stages during myelination. However, it is generally thought
that myelinating glia perceive axonal diameter at the initial stages of myelination, because a
minimum initial diameter is required for axons to be myelinated.
By contrast, axons rearrange their cytoskeleton in response to glial signaling. Myelination,
thus, triggers a second expansion of axonal diameter (Windebank et al., 1985). Whereas the
total number of neurofilaments grossly dictates the diameter of unmyelinated axons, the
myelination-induced axonal expansion maximizes the initial diameter of axons by modulating
the spacing between neurofilaments through phosphorylation (Mata et al., 1992; Hsieh et al.,
1994b). Griffin and colleagues have developed a methodology based on electron micrographic
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data to quantify the levels of neurofilament packing in PNS axons through a parameter that the
authors named nearest neighbour neurofilament distance (NNND). The NNND value indicates
the spacing between orderly distributed neurofilaments and correlates nicely with the
phosphorylation levels of neurofilaments and the diameter of normal myelinated axons (Hsieh
et al., 1994a; Hsieh et al., 1994b; Lunn et al., 2002).
A key glial component in the signaling pathway of myelination-induced axonal expansion is
myelin associated glycoprotein (MAG) (Yin et al., 1998). MAG localizes to the periaxonal
membranes of glial internodes in both CNS and PNS. In the PNS, MAG is enriched at the
paranodal loops of mature Schwann cells (Trapp et al., 1989). Cleveland and colleagues have
analyzed mouse mutants that lack phosphorylation sites at the C-terminal of neurofilaments
and proposed a model in which axonal expansion triggered by myelination starts with MAG-
dependent signaling and, ultimately, targets phosphorylation of neurofilament-M via p75NTR-
dependent activation of cyclin-dependent kinase 5 (cdk-5) and/or ERK1/2 (Garcia et al.,
2003). Moreover, cdk5 mediates phosphorylation of important cytoskeletal proteins in axons
such as tau and MAP1B, and, consequently, regulates the attachment of these proteins to
microtubules, which modulates rates of axonal transport (Matsushita et al., 1996; Wada et
al., 1998; Bu et al., 2002; Dashiell et al., 2002; Kawauchi et al., 2005).
Alternating axonal diameter: an Achilles’ heel of myelinated axons
Axonal expansion caused by phosphorylation of neurofilaments is reversible, thus, axons
decrease their internodal diameter upon demyelination and expand again after remyelination.
Consistent with this observation, axons do not undergo myelination-induced expansion in
unmyelinated segments like at the nodes of Ranvier, where neurofilaments remain
unphosphorylated and, hence, tightly packed (Hsieh et al., 1994b; Sanchez et al., 1996).
Therefore, because of the axon–glial communication, some myelinated axons present
alternating diameter along their length. Here we argue that this alternating pattern is a key
contributor to the axonal dependence on the integrity of the axon–glial interactions after
myelination (Fig. 1B).
While still unmyelinated, the diameter of the axons tends to be uniform along their length,
which provides a linear track for axonal transport. After myelination, some axons display
remarkably uneven diameter, with long segments of spaced phosphoneurofilaments interrupted
by short segments of packed, non-phosphorylated neurofilaments (Fig. 1B). Alternation of
diameter along these axons generates points of retention for axonal transport (i.e. nodal and
paranodal regions present reduced rates of axonal transport and increased accumulation of
organelles when compared with internodes) (reviewed in Salzer, 2003). Finally, one might
picture the paranode as an Achilles’ heel in these myelinated axons, where the creation of an
alternating pattern for axonal diameter might generate regions of potential complications in
axonal transport. Does myelination provide an adaptation mechanism to ensure smooth
transport at each change in axonal diameter?
Cytoskeletal transition at the paranodes
Although perhaps unconventional, we refer to paranodes as the region of transition between
alternations in diameter of myelinated axons. In axons that undergo alternating pattern, the
paranodal cytoskeleton tapers as it approaches the nodes of Ranvier; and we suggest that this
transition between expanded and nonexpanded cytoskeleton is maintained actively by
paranodal modulation of local cytoskeleton (Figs. 1B and 2). The finding that AGJs are linked
to axonal cytoskeleton through the Caspr-dependent recruitment of a paranodal complex with
protein 4.1B, αII-spectrin, βII-spectrin, ankyrin B and actin supports this idea (Gollan et al.,
2002;Denisenko-Nehrbass et al., 2003;Garcia-Fresco et al., 2006;Ogawa et al., 2006). CGT
and Caspr mutants, which are deficient in proteins that are synthesized in glia and axons,
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respectively, exhibit disrupted AGJs stemming from very different mechanisms (Coetzee et
al., 1996;Bhat et al., 2001). The study of these mutants reveals a previously unappreciated
function for the Caspr-mediated link between AGJs and the axonal cytoskeleton in the
maintenance of the cytoskeletal organization as well as axonal transport at the paranodal region.
Disruption of this link leads to the development of axonal swellings at the paranodal region of
the Purkinje axons (Fig. 3B). CGT- and Caspr-mutants exhibit normal myelination-induced
expansion of the axonal cytoskeleton, but do not form the paranodal transverse bands. These
mice, thus, provide a model to selectively study the role of AGJs in the intrinsic transition
between expanded and nonexpanded cytoskeleton that normally takes place in the paranodal
region (Fig. 3A). Ultrastructural analysis revealed that the paranodal regions in CGT and
Caspr mutants are disorganized severely in their local cytoskeleton, as depicted in Fig. 2B. It
is, thus, appealing to propose that the AGJ link with the cytoskeleton stabilizes the transition
between expanded and nonexpanded cytoskeletons along the myelinated axons.
The mechanisms and signaling cascades that direct the cytoskeleton transition at the paranodes
are largely unknown. Does the AGJ/microfilament complex link the microtubules and/or
neurofilaments to the axolemma? Are the paranodes sites for modifications of neurofilaments
that promote a decrease in neurofilament spacing, such as dephosphorylation of C-terminal
neurofilament sidearms or phosphorylation of the neurofilament N-terminal? Are paranodes
sites for regulation of proteins that crosslink microtubules and neurofilaments? Although we
do not have answers for these questions, the model proposed here suggests that they are relevant
and need to be addressed. We propose that the AGJs actively modulate the cytoskeletal
organization beneath the paranodes. This would ensure the spatial segregation and a smooth
transition between expanded internodal and non-expanded nodal cytoskeletons.
Although the molecular link between AGJs and the cytoskeleton and its implications on axonal
transport have been reported only recently, earlier studies by Griffin and others using the
neurotoxin β,β′-iminodipropionitrile (IDPN) pioneered the correlation between paranodal
integrity and disruption in axonal transport (Griffin et al., 1984; Griffin et al., 1987; Parhad
et al., 1987; Griffin and Sheikh, 1999). It was demonstrated that impairments of axonal
transport of neurofilaments induced by IDPN leads to the formation of neurofilament-enriched
swellings and to a passive paranodal demyelination, with displacement of the paranodal loops
towards the internodes (Griffin et al., 1987). These results are consistent with our model and
indicate that the link between AGJs and the paranodal cytoskeleton is sufficiently strong to
create interdependence. In other words, disorganization of the paranodal cytoskeleton leads to
mechanical displacement of myelin loops through their link with the AGJs.
IDPN-induced paranodal swellings indicate that paranodes provide a cytoskeletal track that is
highly susceptible to complications in axonal transport, which is consistent with the idea of a
cytoskeletal transition at the paranodes. However, these experiments did not rule out the
possibility that mechanical displacement of AGJs insults the axolemma, which might be the
major cause of the formation of paranodal swellings. Trauma induced in myelinated axons is
reported to lead to rapid formation of swellings at the nodes of Ranvier (nodal blebs), the
formation of which has been attributed to Ca2+ influx into the axon through the axolemma
(Maxwell et al., 1991; Maxwell and Graham, 1997). Other studies support the hypothesis that
mechanical disruptions of the axolemma lead to formation of axonal swellings through influx
of free Ca2+ and local activation of Ca2+-dependent enzymes, such as proteases (Fitzpatrick
et al., 1998). The development of paranodal swellings in CGT- and Caspr-mutants, where
AGJs do not form and no detectable paranodal demyelination is observed, indicate a causal
link between the formation of AGJs and the organization of paranodal cytoskeleton (Garcia-
Fresco et al., 2006).
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Paranodal swellings in CGT and Caspr mice are observed only in a limited range of myelinated
axon (i.e. axons of Purkinje neurons). This indicates that other compensatory mechanisms act
to stabilize the cytoskeletal transition at the paranodes in the absence of AGJs in other neurons.
AGJ disruption also leads to accumulation of mitochondria at the nodal region in older Caspr
mutants (Einheber et al., in press). The presence of a basal lamina in the PNS nerves might
physically protect the paranodes from developing swellings and, thus, might cause the
accumulation of axonal transport cargo instead at the nodes. Because mitochondria are peculiar
in the way they are transported through the axons with high rates of releases from the molecular
motors, they might be more likely to be trapped on the disorganized paranodal cytoskeleton
than other organelles (Einheber et al., in press).
Other possible mediators of cytoskeletal transition at the paranodes
AGJs are unlikely to be the sole mediators of cytoskeletal transition at the paranodes. PLP/
DM20-null and mosaic mice develop paranodal swellings and myelination-induced axonal
expansion but AGJs form normally in these mice (Griffiths et al., 1998). This observation
indicates that isoforms of PLP might also affect paranodal cytoskeleton through unknown
mechanisms.
Paranodal demyelination with the formation of swellings is also a feature of giant axonal
neuropathy (GAN), an autosomal recessive disorder caused by mutations in the protein
gigaxonin that interferes with axonal transport. In vitro, gigaxonin regulates microtubule
stability by binding and inducing degradation of the microtubule-associated protein 1B
(MAP1B) (Allen et al., 2005). Mutations in gigaxonin disrupt interaction between gigaxonin
and MAP1B (Ding et al., 2002). Interestingly, MAP1B mediates cross talk between
microtubules and actin filaments in axons. Cdk5 phosphorylates MAP1B and the
phosphorylated form of MAP1B was reported recently to be enriched at the paranodes (Soares
et al., 2002).
It is tempting to speculate that MAP1B has an additional role in the paranodal cytoskeletal
transition. Most importantly, is the phosphorylation of MAP1B at the paranodes, a downstream
event of MAG signaling triggered during myelination? Ablation of MAP1B leads to delayed
myelination and myelination-induced axonal expansion (Takei et al., 1997). MAP1B localizes
at neuronal membranes and immuno-precipitates with MAG; moreover, MAP1B
phosphorylation increases when neurons are cocultured with cells that express MAG (Tanner
et al., 2000; Franzen et al., 2001; Dashiell et al., 2002). Is there a correlation between disruption
of gigaxonin binding to MAP1B in GAN and the formation of paranodal swellings?
Identification of additional players in the cytoskeletal transition at the paranodes should help
to elucidate the mechanisms by which myelination modifies the paranodal cytoskeleton.
Limitations of the cytoskeletal transition model
One of the premises of this model is that the feature of myelination-induced axonal expansion
is, in some measure, shared by both the CNS and the PNS axons. At least for the CNS optic
nerves, cytoskeletal expansion of the myelinated part of the axons is dependent on
oligodendrocyte signaling, and the unmyelinated portion of the same axons does not expand
(Sanchez et al., 1996). However, it must be pointed out that the key studies characterizing the
differences between internodal and nodal diameter have been performed in the PNS. It is likely
that the larger diameter of PNS axons together with the existence of a structurally protective
basal lamina facilitates the preservation of local diameter in axonal segments during sample
preparation and ultrastructural detection of the alternating pattern in the PNS rather than CNS.
The existence of nodes of Ranvier in CNS myelinated axons was received initially with much
skepticism, because morphological features such as the ‘nodal constriction’ were not detected
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in these CNS myelinated axons. This was later attributed to difficulties in obtaining proper
cytological fixation in the CNS because under optimal conditions the ‘nodal constrictions’ are
detected in the CNS axons (Bodian, 1951; Nakai, 1954; Pease, 1955). However, CNS axons
seem to be morphologically more diverse than PNS axons. Even in optimal tissue preparations,
CNS nodes of Ranvier are more permeable than the internodes, which probably led to
variability in the morphology and stain of these domains (Bodian, 1951). Another possible
explanation for the variability of morphology in the CNS nodes of Ranvier is the fact that they
are exposed to different environmental cues in a less patterned way compared to PNS fibers
from, for example, the sciatic nerve. External cues modulate the dynamics of actin-based
cytoskeleton and lead to different forms of structural plasticity such as synapse formation and
axonal branching that influence the shape of the nodes of Ranvier (Rosenstein and Leure-
DuPree, 1976; Yiu and He, 2006). This local, actin-based activity might lead to nodal
protrusions and contractions and, thus, mask the morphological detection of neurofilament-
based alternating pattern in the CNS.
Palay and Chan-Palay have described an anatomical point just before the onset of the myelin
sheath as the narrowest portion of the initial segment of the Purkinje axons, where the diameter
drops from about 1 μm to 0.5 μm, and expands again beneath the myelinated sheath (Palay and
Chan-Palay, 1974), however, we are unaware of studies that show precisely that Purkinje axons
indeed undergo alternating pattern. Together these circumstantial observations indicate that
some CNS axons, including Purkinje axons, undergo alternating pattern after myelination, but
further studies are needed to confirm this assumption.
Predictions of the cytoskeletal transition model
Understanding the mechanisms of degeneration of myelinated axons in demyelinating diseases
is relevant to the development of treatments for MS and CMT because axonal degeneration is
the major cause of neurological disabilities associated with these diseases (Bjartmar et al.,
1999; Bjartmar et al., 2003). Here we present a view of the paranodes as a region of axonal
susceptibility to injuries caused by demyelination. Consistent with this view, an early sign of
myelin loss in MS is the mislocalization of Caspr and NF155 (Wolswijk and Balesar, 2003;
Coman et al., 2006; Howell et al., 2006).
The model of cytoskeletal transition at the paranodes makes several predictions that can be
tested and correlated with the available data. Probably the most important prediction is that
partial myelination would insult some axons more than complete demyelination. This would
be the case for myelinated axons that display alternating pattern in their diameter but have lost
the adaptation mechanisms to modulate transition at each alternation. This prediction is
consistent with the phenotype of mutants that have myelination-induced axonal expansion but
lack proper AGJs, such as Caspr and CGT mutants, which develop paranodal swellings. By
contrast, the model predicts that complete abolition of this alternating pattern on axonal
diameter would not lead to the development of axonal swellings. This prediction is also
consistent with the phenotype of mutants that are deficient in the signaling for phosphorylation
of neurofilaments, such as MAG and mice deficient in phosphorylation of neurofilament by
truncation or ablation of neurofilament subunits M or H/ M (Yin et al., 1998; Garcia et al.,
2003).
A simplified summary of relevant observations is presented in Fig. 4, to conceptualize the
predictions of our model. Interpretation of axonal degeneration in most demyelinating diseases
and animal models should not be narrowed down to a single general mechanism. We have
selected mutants for discussion that display changes in axonal diameter because of changes in
neurofilament spacing, and we have analyzed a very specific parameter of axonal damage, the
development of paranodal swellings. Studies using NNND as a parameter should be
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instrumental in better characterizing the intrinsic deficiencies in the alternating pattern
generated by partial myelination and to test the model proposed here.
Conclusions and remarks
Here, we propose a model in which alternations in axonal diameter induced by myelination
generate axonal dependence on the proper cytoskeletal transition at each paranode. An
important prediction from this model is that disruptions in AGJs will promote less damage if
axons do not present the alternating pattern in their diameter. One might wonder whether the
development of paranodal swellings in mice with disrupted AGJs (CGT and Caspr) would be
attenuated in a mouse background in which phosphorylation of neurofilaments induced by
myelination is abolished (neurofilament-M mutants). In addition, this raises the hypothesis that
drugs that disrupt phosphorylation of neurofilament-M specifically might have the potential
to either attenuate or partially prevent paranodal swellings that are promoted by disruption in
the AGJs. Finally, the model for cytoskeletal transition at the paranodes provides a novel
perspective to speculate on the role of axon–glial interactions beyond the membrane
specializations, down into the core of the specialized axonal cytoskeleton.
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Fig. 1. Landmarks for changes in axons and glia after myelination
(A) Polarization of both axons and glia in the node of Ranvier and adjacent domains. The
schematic is not to scale but the difference in axonal diameter between nodes of Ranvier and
internodes is reported to be up to five fold. Similarities between myelination by
oligodendrocytes (CNS) and Schwann cells (PNS) are presented. Nodes of Ranvier contact
processes of perinodal astrocytes in the CNS and microvilli of Schwann cells in the PNS. We
have omitted this information as well as the basal lamina in the PNS from the schematic, aiming
to emphasize the similarities between the two myelination processes. (B) Phosphorylation of
neurofilaments has a major role in increasing axonal diameter through myelination-dependent
signaling.
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Fig. 2. Schematic of the main changes in axons and glia that are promoted by myelination
(A) In the internodal region the glial cytoplasm is extruded, which leads to compaction of the
myelin sheath and remarkable expansion of the cytoskeleton in some axons. (B) In the
juxtaparanodal region, the specific glial and axonal components cluster during myelination and
establish an axon–glial scaffold with no specialized ultrastructure. (C) In the paranodal region,
local clustering of glial NF155 and axonal Caspr, Cont, 4.1B, αII and βII spectrin, and ankyrin
B results in the establishment of axon–glial junctions. (D) In the nodal region, either Schwann
cell microvilli (PNS) or perinodal astrocytes (CNS) interact with nodal axolemmal
components. Nodal cytoskeletal proteins NF186, ankyrinG and bIV spectrin coordinate the
clustering of the voltage-gated Na+ channels.
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Fig. 3. Model for cytoskeletal transition at the paranodes
(A) Myelination induces phosphorylation of neurofilaments and increases the spacing between
neurofilaments at the internodes (1), but not at the nodes of Ranvier where neurofilaments are
more tightly packed (2). This periodic signaling along myelinated axons creates what we call
the alternating pattern for axonal diameter. The transition between expanded and nonexpanded
cytoskeleton happens at the paranodal region (3), where AGJs (white arrowheads) have a role
in maintaining this smooth transition, ensuring organization of tracks for axonal transport (4).
The inset shows the known molecular components of AGJs that link to the axonal cytoskeleton.
Although Caspr is delivered to the paranodal axolemma only when associated with Cont, this
association has been shown to inhibit Cont binding to NF155 (Charles et al., 2002; Gollan et
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al., 2003). * indicates that the association of Caspr to NF155/Cont might be mediated by other
proteins. Yellow circles represent organelles that are transported along microtubules. (B) If
AGJs are disrupted and the signaling for cytoskeletal expansion at the internodes is still intact,
the axonal diameter undergoes alternating pattern (1 and 2) but the transition of diameters is
not modulated by AGJs (5). In the absence of proper transition, expanded cytoskeleton invades
regions of nonexpanded cytoskeleton, and vice-versa, causing cytoskeletal disorganization at
the paranodal region (6) and generation of a site for impairment in transport (7) and potential
formation of swellings.
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Fig. 4. Correlation between predictions of the cytoskeletal transition model and data from mouse
mutants
(A) Normal myelinated axons present myelination-induced axonal expansion at the internodes,
intact AGJs and proper transition of cytoskeleton at the paranodes. (B) Disruption of AGJs in
axons under proper myelination-induced cytoskeletal expansion leads to disorganized
transition of cytoskeleton, impairments in axonal transport and the formation of paranodal
swellings, which is consistent with the phenotypes of CGT and Caspr mutants (Garcia-Fresco
et al., 2006). (C) Disruption of signaling in myelination-induced axonal expansion per se would
not lead to formation of paranodal swellings as in the case of MAG and neurofilament mutants
(Yin et al., 1998; Elder et al., 2001; Garcia-Fresco et al., 2006). Note that, as discussed for the
PLP mutants under the heading ‘Other possible mediators of cytoskeletal transition at the
paranodes’, not all the reported paranodal swellings correlate with disruptions of the axon–
glial junctions.
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